TECO and DIESSE announce strategic partnership for the distribution of CHORUS systems and AUTO-DAT in DACH (Germany, Austria and Switzerland)
Friday 22 March 2024Monteriggioni, 22 March 2024 – Swiss-based TECOmedical Group is since 24 years a leading provider of in-vitro specialty test systems in the DACH region in different areas of medical diagnostic testing. Since July 2020 TECOmedical is part of the Eurobio Scientific Group. TECOmedical and DIESSE Diagnostica Senese S.p.A. Società Benefit, a company with 44 years of experience in the world of laboratory diagnostics, announce that they have entered into a commercial agreement for the exclusive distribution of CHORUS Trio, CHORUS EVO and AUTO-DAT analyzers in the DACH markets.
The cutting-edge Immunochemistry line, which includes CHORUS TRIO, the new CHORUS EVO as well as the AUTO-DAT analyzer for immunometric assay is developed and manufactured in Italy by DIESSE and will be distributed throughout the DACH region by TECOmedical dedicated team of sales and marketing experts.
Innovative technology, modern design, quality and reliability of analytical results in mono-test format, the largest test menu available with >150 tests all make CHORUS line the ideal solution for immunochemistry assay, while ensuring maximum flexibility in organizing the clinical laboratory's workflow.
AUTO-DAT, analytical system for diagnostic investigations with seroagglutination technique in microplate, allows the standardization of protocols. The analyzer provides automation of mixing, incubation and reading of results based on computer vision to support objective reports.
Luigi Nava, Commercial Director of DIESSE commented: “The innovation offered by the CHORUS systems and the AUTO-DAT analyzer will allow laboratories in the DACH area to increase their clinical effectiveness. We are very happy to share this opportunity with TECOmedical competent, professional and motivated team. Together we will work to meet IVD laboratory’s needs, combining DIESSE product expertise and TECOmedical’s skills and professional organization.
Marieluise Wippermann, CEO of TECOmedical, expressed: “The alliance between TECOmedical and DIESSE will simplify the effective implementation of DIESSE innovative solutions in Clinics and Laboratories in the DACH region in order to support patient care and follow our credo “always your partner".
The alliance between TECOmedical and DIESSE will simplify the effective implementation of DIESSE innovative solutions in the DACH labs.
